- Home
- KRMD vs CDLX Comparison
KRMD vs CDLX Comparison
Compare KRMD & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- CDLX
- Stock Information
- Founded
- KRMD 1980
- CDLX 2008
- Country
- KRMD United States
- CDLX United States
- Employees
- KRMD N/A
- CDLX N/A
- Industry
- KRMD Medical/Dental Instruments
- CDLX Computer Software: Programming Data Processing
- Sector
- KRMD Health Care
- CDLX Technology
- Exchange
- KRMD Nasdaq
- CDLX Nasdaq
- Market Cap
- KRMD 187.5M
- CDLX 180.4M
- IPO Year
- KRMD N/A
- CDLX 2018
- Fundamental
- Price
- KRMD $4.60
- CDLX $2.98
- Analyst Decision
- KRMD Strong Buy
- CDLX Hold
- Analyst Count
- KRMD 5
- CDLX 6
- Target Price
- KRMD $4.50
- CDLX $5.90
- AVG Volume (30 Days)
- KRMD 157.7K
- CDLX 979.5K
- Earning Date
- KRMD 03-12-2025
- CDLX 03-13-2025
- Dividend Yield
- KRMD N/A
- CDLX N/A
- EPS Growth
- KRMD N/A
- CDLX N/A
- EPS
- KRMD N/A
- CDLX N/A
- Revenue
- KRMD $31,993,796.00
- CDLX $293,468,000.00
- Revenue This Year
- KRMD $20.04
- CDLX N/A
- Revenue Next Year
- KRMD $14.15
- CDLX $3.49
- P/E Ratio
- KRMD N/A
- CDLX N/A
- Revenue Growth
- KRMD 11.57
- CDLX N/A
- 52 Week Low
- KRMD $2.01
- CDLX $2.76
- 52 Week High
- KRMD $5.05
- CDLX $20.52
- Technical
- Relative Strength Index (RSI)
- KRMD 66.80
- CDLX 36.80
- Support Level
- KRMD $4.16
- CDLX $2.76
- Resistance Level
- KRMD $4.40
- CDLX $4.05
- Average True Range (ATR)
- KRMD 0.23
- CDLX 0.26
- MACD
- KRMD 0.03
- CDLX -0.04
- Stochastic Oscillator
- KRMD 63.71
- CDLX 10.69
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.